XASX
ONE
Market cap100mUSD
Sep 17, Last price
0.16AUD
1D
-3.03%
1Q
-5.88%
Jan 2017
-97.48%
IPO
-95.82%
Name
Oneview Healthcare PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Oneview Healthcare PLC, headquartered in Dublin, Ireland since its establishment in 2008, specializes in furnishing bespoke software and expert consulting services. These offerings are tailored for the global healthcare industry, with a presence spanning Ireland, the United States, Australia, Asia, and the Middle East. The company's core offerings revolve around its Care Experience Platform (CXP), which includes several distinct solutions: CXP Cloud Start: Designed to enable clients to seamlessly deploy essential digital engagement functionalities across their entire organizational footprint. CXP Cloud Enterprise: This solution empowers patients and their relatives to communicate virtually with healthcare providers, while also providing access to vital educational resources and health-related information. CXP Enterprise On-Prem: A robust on-premise offering engineered to address diverse institutional requirements, suitable for a wide range of facilities, from new construction projects to existing hospitals utilizing legacy infrastructure. Furthermore, Oneview Healthcare also provides specialized tools aimed at enhancing patient and family empowerment, optimizing the overall patient experience, facilitating remote virtual care delivery, and offering solutions like digital room signage and interactive patient communication boards.
Key people
Joseph Rooney
Independent Non-Executive Chairman of the Board · since 2017
James Fitter
Chief Executive Officer, Executive Director
John Kelly
Chief Financial Officer · since 2019
Douglas Collins
Chief Executive Officer � Middle East and North Africa · since 2013
Jeff Fallon
President - North America · since 2014
Niall ONeill
Chief Operating Officer · since 2014
Phillip Urrea
Chief Technology Officer
Mark McCloskey
President, Executive Director
Grace Jaime
Global Head of Business Excellence · since 2015
Oran Rigby
Executive Medical Director · since 2017
Nick Brown
joint Company Secretary · since 2017
Patrick Masterson
Chief Commercial Officer and Company Secretary
Lyle Berkowitz
Non-Executive Independent Director · since 2016
Non-Executive Independent Director · since 2018
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||